Jordan Feld, University of Alberta

Research

Adjuvanted Vaccine Hepatitis C Virus Peptide-Based Vaccine Vaccine Covid-19 Human Immune Cells Inflammation Interferon-Lambda

Latest funding

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate
CIHR · 2023 · Principal investigator
$2,050,829
Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate
CIHR · 2023 · Principal investigator
$512,707
Characterization of interferon-lambda 1 as a treatment for COVID-19
CIHR · 2020 · Principal investigator
$499,775

All 3 grants and awards

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Principal investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Meier-Stephenson, Vanessa; Cooper, Curtis L; Feld, Jordan J; Houghton, Michael; Richer, Lawrence P

Keywords: Adjuvanted Vaccine; Hepatitis C Virus; Peptide-Based Vaccine; Vaccine

$2,050,829

Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate

Principal investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Meier-Stephenson, Vanessa; Cooper, Curtis L; Feld, Jordan J; Houghton, Michael; Richer, Lawrence P

Keywords: Adjuvanted Vaccine; Hepatitis C Virus; Peptide-Based Vaccine; Vaccine

$512,707

Characterization of interferon-lambda 1 as a treatment for COVID-19

Principal investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Therapeutics

Principal investigators: Tyrrell, D. Lorne J; Feld, Jordan J

Keywords: Covid-19; Human Immune Cells; Inflammation; Interferon-Lambda; Sars-Cov-2

$499,775

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Adjuvanted Vaccine Dear Professor Feld, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on adjuvanted vaccine connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Phase 1 randomized, double-blinded, placebo-controlled clinical trial of an adjuvanted protein-based Hepatitis C Virus (HCV) vaccine candidate" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]